Nuvama Investment Banking is a proud banker to Jupiter Hospitals in its continued journey to healthcare excellence.

Deal Details:

  • Jupiter Hospitals successfully completed a Pre-IPO placement to marquee long only Investors at the IPO Price
  • The IPO received an overwhelming response from investors to emerge as:
    • Highest subscribed Hospitals IPO
    • Amongst the Top 3 highest subscribed IPOs in the past 2 years
  • IPO saw a stellar listing with stock price closing at 46% premium to issue price#

Contribution:

  • Effectively positioned Jupiter Hospitals as a key Multi Specialty hospital chain in Western India with a distinguished business model and a ‘patient first’ ideology
  • Nuvama garnered participation from a diverse investor set including Global Sovereign Funds, LO Flls, Mutual Funds, Insurance Companies
  • Pushed the story aggressively through our distribution channel to garner strong interest in HNI & Retail category resulting in overall 13 lakh+ applications

About:

  • Jupiter Lite Line Hospitals Ltd Is a key tertiary and quaternary healthcare chain in the Mumbai Metropolitan Area (MMR) and western region of India with a total bed capacity of 1,194 hospital beds across three hospitals as of March 31, 2023@.

Book Running Lead Manager to the IPO of Tarsons Products Limited

I] TRANSACTION SYNOPSIS

IPO Size ₹ 10,235 mn
IPO Structure (Primary / OFS) 15% / 85%
Post Issue Dilution 29.07%
IPO Price ₹ 662
Subscription (QIB* / HNI / Retail) 115.5x / 183.2x / 8.9x
Total number of applications# 1,912,663

II] SELECT ANCHOR INVESTORS AND ANCHOR BOOK

  • ADIA
  • Birla MF
  • Government of Singapore
  • ICIC Prudential MF
  • Mirae MF
  • Nippon MF
  • Stewart Investors

III] DEAL HIGHLIGHTS

  • Highest subscribed Healthcare IPO (Ex Pharma)^
  • Healthy subscription with more than 19 Lacs applications
    • 100% of anchor book was allocated to LO Investors
  • We provided end-to-end client handholding and guidance on various deal contours and timing

*Excluding Anchor
# Before technical rejections
^IPOs since 2010 considered

Book Running Lead Manager to the IPO of Vijaya Diagnostic Centre Limited

Deal Highlights:

Largest Diagnostic Company IPO in India
  • Largest Diagnostic IPO^ in India
  • Participation by all category of investors – LO FIIs, Sovereign Wealth Fund, Mutual Funds, Life Insurance Companies and Family Office
  • Launched within 12 weeks since DRHP Filing
~2.4 lacs
Applications Received
Allocation to long only investors in Anchor Book~16%
Listing day premium

Our Contribution:

  • Ensured early participation from high quality Long Only FIIs, MFs, Insurance Companies and marquee Indian Family Office in the issue to give confidence for launch of deal
34%
Share of the Anchor portion in 3 Bank Syndicate
14
Highest number of investors converted in anchor
#1 Procurer
38%# share of the overall Retail and HNI portion
  • Procured 100% and ~90% of QIB subscription on Day-1 and Day-2 respectively
  • Provided end-to-end client handholding and guidance on various deal contours and timing

^ In terms of issue size; #Under Finalization